sabinene has been researched along with Non-alcoholic Fatty Liver Disease in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (43.48) | 24.3611 |
| 2020's | 13 (56.52) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SH; Huang, CY; Lee, CN; Li, ML; Yao, HT | 1 |
| Chen, Z; He, B; Jiang, J; Lu, Z; Wu, L; Yan, M; Yu, J | 1 |
| Ferro, Y; Maurotti, S; Mazza, E; Mollace, V; Montalcini, T; Musolino, V; Pujia, A; Pujia, R; Sciacqua, A | 1 |
| Chen, ZY; Nie, YM; Xu, SM; Yan, JB; Zhang, S | 1 |
| Casagrande Denardin, C; Casanova Petry, C; da Costa Escobar Piccoli, J; Erminda Schreiner, G; Gonçalves, IL; Klock, C; Lima Feksa, D; Manfredini, V; Martinez Oliveira, P; Muller de Moura Sarmento, S; Tejada Nunes, V | 1 |
| Efferth, T; Jiang, J; Shan, L; Shi, Z; Wang, L; Yan, L | 1 |
| Ampawong, S; Burana-Osot, J; Chantip, S; Isarangkul, D; Kanjanapruthipong, T; Kengkoom, K; Phattanawasin, P; Sotanaphun, U; Tirawanchai, N | 1 |
| Amodio, N; Bedossa, P; Bosco, F; Caffrey, R; Carresi, C; Ehrlich, J; Gliozzi, M; Juli, G; Macrì, R; Maiuolo, J; Marioneaux, J; Mollace, R; Mollace, V; Muscoli, C; Musolino, V; Nucera, S; Palma, E; Ruga, S; Salvemini, D; Sanyal, AJ; Scarano, F; Scicchitano, M; Tassone, P; Walker, R; Zito, MC | 1 |
| Chae, HJ; Hoang, TH; Kang, SI; Kim, J; Lee, CH; Lee, GH; Lee, HY; Lee, JS; Park, SA; Peng, C | 1 |
| Chen, H; Huang, C; Ke, Z; Li, Y; Tan, S; Zhao, Y; Zhou, Z | 1 |
| Cao, Y; Chen, T; Chen, Y; Feng, K; Kan, Q; Liu, G; Zhu, X | 1 |
| Egusa, Y; Fukumura, Y; Inomoto, T; Nishimuta, S; Nishinaka, T; Shimizu, K; Terada, T; Tomita, K; Yoshimura, M | 1 |
| Hosseinzadeh-Attar, MJ; Naeini, F; Namkhah, Z; Ostadrahimi, A; Tutunchi, H | 1 |
| Chen, Z; Cui, D; He, B; Jiang, J; Luo, M; Shi, Z; Wu, L; Xu, S; Yan, J; Yan, M; Zhang, S | 1 |
| Badmaev, V; Ho, CT; Lai, CS; Li, MY; Li, S; Pan, MH; Tsai, ML; Wu, JC; Yang, G | 1 |
| Chen, Z; He, B; Hong, W; Jiang, J; Wu, L; Yan, M | 1 |
| Aparecida da Costa Güllich, A; Coelho, RP; da Costa Escobar Piccoli, J; Dal Ponte, ES; Feksa, DL; Manfredini, V | 1 |
| Janda, E; Lascala, A; Martino, C; Mollace, V; Oliverio, M; Parafati, M; Pellegrino, D; Salerno, R | 1 |
| Choi, BK; Han, HY; Kim, TW; Lee, DR; Lee, HJ; Lee, SK | 1 |
| Chen, ZY; He, BH; Jiang, JP; Li, JS; Yan, MX | 1 |
| Britti, D; Brunelli, E; Coscarelli, F; Costa, N; Ehrlich, J; Isidoro, C; Janda, E; Lascala, A; Mollace, V; Morittu, VM; Parafati, M; Rizzuto, A; Trimboli, F | 1 |
| Chen, ZY; He, BH; Jiang, JP; Li, JS | 1 |
| Burke, AC; Huff, MW; Mulvihill, EE | 1 |
2 review(s) available for sabinene and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
Topics: Citrus; Flavanones; Flavonoids; Humans; Non-alcoholic Fatty Liver Disease; Risk Factors | 2021 |
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antioxidants; Atherosclerosis; Citrus; Diabetes Mellitus, Type 2; Dietary Supplements; Flavonoids; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Non-alcoholic Fatty Liver Disease; Overweight; Risk Factors | 2016 |
1 trial(s) available for sabinene and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease.
Topics: Citrus; Hyperuricemia; Non-alcoholic Fatty Liver Disease; Risk Factors; Uric Acid | 2022 |
20 other study(ies) available for sabinene and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Topics: Aldehydes; Animals; Body Weight; Citrus; Diet, High-Fat; Eating; Fatty Acids; Feces; Fruit; Hep G2 Cells; Humans; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2022 |
Pure total flavonoids from citrus improve nonalcoholic steatohepatitis liver inflammatory responses by regulating the CCL2/CCR2-PI3K-Akt signal transduction pathway.
Topics: Animals; Citrus; Cytokines; Flavonoids; Lipids; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction | 2023 |
Pure total flavonoids from citrus alleviate oxidative stress and inflammation in nonalcoholic fatty liver disease by regulating the miR-137-3p/NOXA2/NOX2 pathway.
Topics: Citrus; Flavonoids; Inflammation; MicroRNAs; Non-alcoholic Fatty Liver Disease; Oxidative Stress; RNA, Messenger | 2023 |
Aqueous extract of pummelo pulp (Citrus maxima) improves the biochemical profile and reduces the inflammation process in Wistar rats with non-alcoholic fatty liver disease.
Topics: Animals; Citrus; Diet, High-Fat; Inflammation; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2023 |
Hepatoprotective and anti-inflammatory effects of total flavonoids of Qu Zhi Ke (peel of Citrus changshan-huyou) on non-alcoholic fatty liver disease in rats via modulation of NF-κB and MAPKs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Citrus; Diet, High-Fat; Flavonoids; Gene Expression Regulation; Liver; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Non-alcoholic Fatty Liver Disease; Phosphorylation; Plant Extracts; Protective Agents; Rats, Sprague-Dawley | 2019 |
A combination extract of kaffir lime, galangal, and lemongrass maintains blood lipid profiles, hepatocytes, and liver mitochondria in rats with nonalcoholic steatohepatitis.
Topics: Alpinia; Animals; Antioxidants; Citrus; Cymbopogon; Hepatocytes; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Plant Extracts; Rats; Rats, Sprague-Dawley; Simvastatin | 2020 |
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease.
Topics: Animals; Citrus; Diet, Western; Disease Models, Animal; Dyslipidemias; Gene Expression; Humans; Inflammation; MAP Kinase Kinase 4; Mice; Non-alcoholic Fatty Liver Disease; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Polyphenols | 2020 |
Citrus Peel Extract Ameliorates High-Fat Diet-Induced NAFLD via Activation of AMPK Signaling.
Topics: AMP-Activated Protein Kinases; Animals; Citrus; Diet, High-Fat; Disease Models, Animal; Endoplasmic Reticulum; Freeze Drying; Humans; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Plant Extracts; Rats; Reactive Oxygen Species; Signal Transduction | 2020 |
Citrus reticulata Blanco peel extract ameliorates hepatic steatosis, oxidative stress and inflammation in HF and MCD diet-induced NASH C57BL/6 J mice.
Topics: Animals; Choline; Citrus; Diet, High-Fat; Disease Models, Animal; Fruit; Humans; Liver; Male; Methionine; Mice; Mice, Inbred C57BL; NF-E2 Transcription Factor; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Plant Extracts | 2020 |
Dietary citrus peel essential oil ameliorates hypercholesterolemia and hepatic steatosis by modulating lipid and cholesterol homeostasis.
Topics: Animals; Biomarkers; Cholesterol; Citrus; Dietary Fats, Unsaturated; Dietary Supplements; Disease Models, Animal; Homeostasis; Hypercholesterolemia; Lipidomics; Lipids; Lipogenesis; Liver; Male; Non-alcoholic Fatty Liver Disease; Oils, Volatile; Rats; Rats, Sprague-Dawley | 2020 |
Dietary calamondin supplementation slows the progression of non-alcoholic fatty liver disease in C57BL/6 mice fed a high-fat diet.
Topics: Adipose Tissue; Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Body Weight; Chemokine CCL2; Citrus; Diet; Diet, High-Fat; Dietary Supplements; Gene Expression; Inflammation; Insulin; Lipid Metabolism; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2021 |
Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
Topics: Animals; Bacteria; Bile Acids and Salts; Citrus; Diet, High-Fat; Disease Models, Animal; Dysbiosis; Flavonoids; Gastrointestinal Microbiome; Intestines; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Plant Extracts; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction | 2021 |
Combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts suppresses obesity and hepatic steatosis in high-fat diet induced obese mice.
Topics: Adipogenesis; Animals; Anti-Obesity Agents; Biomarkers; Camellia sinensis; Citrus; Diet, High-Fat; Dietary Supplements; Ethnopharmacology; Flavones; Food Handling; Fruit; Litchi; Male; Methylation; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Plant Extracts; Plant Leaves; Polyphenols; Taiwan | 2017 |
Pure total flavonoids from citrus improve non-alcoholic fatty liver disease by regulating TLR/CCL signaling pathway: A preliminary high-throughput 'omics' study.
Topics: Animals; Chemokines, CC; Citrus; Diet, High-Fat; Disease Models, Animal; Flavonoids; Inflammation; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; RNA, Messenger; Signal Transduction; Toll-Like Receptors | 2017 |
Extract of Citrus maxima (pummelo) leaves improve hepatoprotective activity in Wistar rats submitted to the induction of non-alcoholic hepatic steatosis.
Topics: Animals; Antioxidants; Cholesterol; Citrus; Diet, High-Fat; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Plant Extracts; Plant Leaves; Protective Agents; Rats; Rats, Wistar; Triglycerides | 2018 |
Analysis of proautophagic activities of Citrus flavonoids in liver cells reveals the superiority of a natural polyphenol mixture over pure flavones.
Topics: Apigenin; Autophagy; Cell Line; Citrus; Dose-Response Relationship, Drug; Flavonoids; Hep G2 Cells; Humans; Hydrolysis; Liver; Luteolin; Non-alcoholic Fatty Liver Disease; Polyphenols; Toxicity Tests | 2018 |
Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Body Weight; Citrus; Diet, High-Fat; fas Receptor; Flavonoids; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Plant Extracts; PPAR gamma; Protein Kinases; Random Allocation; Silymarin; Sterol Regulatory Element Binding Protein 1 | 2019 |
[Effect of pure total flavonoids from citrus on hepatic SIRT1/PGC-1alpha pathway in mice with NASH].
Topics: Animals; Citrus; Fatty Liver; Flavonoids; Inflammation; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sirtuin 1; Transcription Factors | 2014 |
Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome.
Topics: Animals; Anti-Obesity Agents; Autophagy; Biomarkers; Citrus; Diet, Western; Dietary Supplements; Disease Models, Animal; Fruit; Humans; Italy; Lipid Droplets; Lipotropic Agents; Liver; Metabolic Syndrome; Microtubule-Associated Proteins; Non-alcoholic Fatty Liver Disease; Obesity; Plant Extracts; Polyphenols; Random Allocation; Rats, Wistar; Ultrasonography | 2015 |
Regulation of pure total flavonoids from Citrus on TH17/Treg balance in mice with NASH.
Topics: Animals; Citrus; Cytokines; Flavonoids; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; T-Lymphocytes, Regulatory; Th17 Cells | 2015 |